PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.25%
Negative revenue growth while ACB.TO stands at 26.47%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-11.81%
Negative gross profit growth while ACB.TO is at 4969.77%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1070.05%
Negative EBIT growth while ACB.TO is at 37.92%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1070.05%
Negative operating income growth while ACB.TO is at 27.42%. Joel Greenblatt would press for urgent turnaround measures.
433.16%
Net income growth above 1.5x ACB.TO's 52.29%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
306.74%
EPS growth above 1.5x ACB.TO's 66.76%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
306.74%
Diluted EPS growth above 1.5x ACB.TO's 66.76%. David Dodd would see if there's a robust moat protecting these shareholder gains.
17.10%
Share reduction more than 1.5x ACB.TO's 43.71%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
16.43%
Diluted share reduction more than 1.5x ACB.TO's 43.71%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
437.30%
Positive OCF growth while ACB.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-403.23%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
197.22%
Positive long-term OCF/share growth while ACB.TO is negative. John Neff would see a structural advantage in sustained cash generation.
197.22%
Positive OCF/share growth while ACB.TO is negative. John Neff might see a comparative advantage in operational cash viability.
750.80%
Positive 3Y OCF/share CAGR while ACB.TO is negative. John Neff might see a big short-term edge in operational efficiency.
253.30%
Net income/share CAGR above 1.5x ACB.TO's 23.34% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
253.30%
Positive 5Y CAGR while ACB.TO is negative. John Neff might view this as a strong mid-term relative advantage.
386.95%
Positive short-term CAGR while ACB.TO is negative. John Neff would see a clear advantage in near-term profit trajectory.
964.68%
10Y equity/share CAGR above 1.5x ACB.TO's 88.72%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
964.68%
5Y equity/share CAGR above 1.5x ACB.TO's 244.67%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
2364.73%
3Y equity/share CAGR above 1.5x ACB.TO's 627.34%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.82%
Firm’s AR is declining while ACB.TO shows 241.61%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.96%
Inventory is declining while ACB.TO stands at 84.28%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
48.98%
Asset growth at 50-75% of ACB.TO's 73.02%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
28.76%
Similar to ACB.TO's 26.70%. Walter Schloss finds parallel capital usage or profit distribution strategies.
18.59%
Debt shrinking faster vs. ACB.TO's 52.43%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
10.45%
R&D dropping or stable vs. ACB.TO's 147.50%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
34.18%
SG&A declining or stable vs. ACB.TO's 115.92%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.